doi:10.3969/j.issn.1673-8640.2019.11.018

Abstract

CLC Number:

R446.1

Figures/Tables 1

References 8

[1]	LIPPI G,BECAN-MCBRIDE K,BEHÚLOVÁ D,et al. Preanalytical quality improvement:inquality we trust[J]. Clin Chem Lab Med,2013,51(1):229-241.
[2]	LIPPI G,MATTIUZZI C,FAVALORO E J.Pre-analytical variability and quality of diagnostic testing. Looking at the moon and gazing beyond the finger[J]. N Z J Med Lab Sci,2015,69:4-8.
[3]	汪怀周,方雯,陈明坤,等. 真空采血管采血量对常用临床生化检验项目结果的影响[J],检验医学,2017,32(2):94-98.
[4]	Clinical and Laboratory Standards Institute. Collection of diagnostic venous blood specimens[S]. GP41,CLSI,2017.
[5]	KO D H,WON D,JEONG T D,et al.Comparison of red blood cell hemolysis using plasma and serum separation tubes for outpatient specimens[J]. Ann Lab Med,2015,35(2):194-197.
[6]	张凌云,费丽娜. 标本溶血对生化检验结果准确性的影响及预防对策[J]. 中国现代药物应用,2018,12(22):217-219.
[7]	刘源,许汪斌,代冬梅. 血乳酸的生理代谢及临床意义[J]. 临床合理用药杂志,2013,6(5):174-175.
[8]	ARTIOLI G G,BERTUZZI R C,ROSCHEL H,et al. Determining the contribution of the energy systems during exercise[J]. J Vis Exp,2012,61:pii:3413.

促凝管	例数	K⁺（mmol/L）	CO₂（mmol/L）	CK（IU/L）	LDH（IU/L）
T_有	22	3.93±0.04	26.33±0.47	125.74±6.06	157.75±25.61
T_无	22	3.93±0.04	26.08±0.43^*	125.44±6.01	158.22±26.06
G_有	22	4.00±0.05	26.61±0.46	126.25±6.09	159.54±25.84
G_无	22	3.94±0.04^#	26.44±0.48	126.02±6.03	157.60±25.07
促凝管	HBDH（IU/L）	ALT（IU/L）	AST（IU/L）	Hcy（μmol/L）	乳酸（mmol/L）
T_有	127.71±4.62	27.79±4.99	19.42±0.99	10.53±0.41	2.20±0.10
T_无	127.29±4.81	27.92±4.93	19.46±1.02	10.54±0.42	2.15±0.10^*
G_有	132.04±5.62	27.92±4.97	19.17±1.11	10.44±0.41	2.24±0.12
G_无	129.33±5.00	27.96±4.95	19.21±1.04	10.49±0.41	2.21±0.11^#

促凝管	例数	K⁺（mmol/L）	CO₂（mmol/L）	CK（IU/L）	LDH（IU/L）
T_有	22	3.93±0.04	26.33±0.47	125.74±6.06	157.75±25.61
T_无	22	3.93±0.04	26.08±0.43^*	125.44±6.01	158.22±26.06
G_有	22	4.00±0.05	26.61±0.46	126.25±6.09	159.54±25.84
G_无	22	3.94±0.04^#	26.44±0.48	126.02±6.03	157.60±25.07
促凝管	HBDH（IU/L）	ALT（IU/L）	AST（IU/L）	Hcy（μmol/L）	乳酸（mmol/L）
T_有	127.71±4.62	27.79±4.99	19.42±0.99	10.53±0.41	2.20±0.10
T_无	127.29±4.81	27.92±4.93	19.46±1.02	10.54±0.42	2.15±0.10^*
G_有	132.04±5.62	27.92±4.97	19.17±1.11	10.44±0.41	2.24±0.12
G_无	129.33±5.00	27.96±4.95	19.21±1.04	10.49±0.41	2.21±0.11^#

[1]	FAN Lieying. Research status and application prospects of biomarkers for membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1111-1114.
[2]	SUN Lincheng, LI Jianfeng, CHENG Weili, JI Panyun. Roles of anti-PLA2R IgG4 antibody and PLA2R IgG4/IgG ratio in primary membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1115-1120.
[3]	LIU Qingyang, YUAN Jianming, XIA Jinjun, JIANG Fengying, WANG Qiubo, WANG Xiaoming. CXCL9 as a potential diagnostic marker of rheumatoid arthritis based on GEO database and experimental verification [J]. Laboratory Medicine, 2023, 38(12): 1121-1129.
[4]	YANG Xiao, LI Enling, WU Lixia, DAI Yingxin, WANG Zhiqing, HUANG Hao, ZHENG Bing. Influence of cytoplasmic antinuclear antibody on indirect immunofluorescence assay based antineutrophil cytoplasmic antibody determination [J]. Laboratory Medicine, 2023, 38(12): 1135-1140.
[5]	XIANG Jin, LIU Aiping, HU Yao, WU Zhiyuan, CAO Guojun, GUAN Ming. ANA profiles in COVID-19 patients and influence of serum heat-inactivation on ANA determination [J]. Laboratory Medicine, 2023, 38(12): 1141-1146.
[6]	CHENG Yu, XU Zhen, LU Liu, DING Menglei, YU Shanshan, ZONG Ming, FAN Lieying. Expression and risk factors of anti-ACE-2 antibody in serum of patients with COVID-19 [J]. Laboratory Medicine, 2023, 38(12): 1147-1152.
[7]	. [J]. Laboratory Medicine, 2023, 38(12): 1153-1156.
[8]	. [J]. Laboratory Medicine, 2023, 38(12): 1157-1159.
[9]	WANG Hongling, LIU Mengna, BAI Ping, LIAO Huanjin. Risk factors of relapse following allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia [J]. Laboratory Medicine, 2023, 38(12): 1160-1166.
[10]	YANG Xilan, WANG Jinyu, LIU Shuyu, ZHAN Yiyang, LIU Jing, JIA Jian. Correlation between hyperlipidemia and endothelial microparticles in elderly patients from Gulou Community in Nanjing [J]. Laboratory Medicine, 2023, 38(12): 1167-1172.
[11]	DAI Fangfang, LU Xinxin, YU Yanhua, CHEN Ming, SUN Guizhen. Analysis of Mycobacterium infection in HIV/AIDS patients [J]. Laboratory Medicine, 2023, 38(12): 1173-1176.
[12]	GU Yu, LIANG Xiaoyan, MA Shenghui, TONG Na, CHENG Mingyan, YAN Zejun. Expression and near-term prognostic predictive value of plasma biomarkers in chronic kidney disease patients with thromboembolism [J]. Laboratory Medicine, 2023, 38(12): 1177-1182.
[13]	. [J]. Laboratory Medicine, 2023, 38(12): 1183-1185.
[14]	. [J]. Laboratory Medicine, 2023, 38(12): 1186-1190.
[15]	. [J]. Laboratory Medicine, 2023, 38(12): 1191-1194.

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 1

References 8

Related Articles 15

Recommended Articles

Metrics